Literature DB >> 2207502

Mechanisms for cardiac depression induced by phorbol myristate acetate in working rat hearts.

M Karmazyn1, J E Watson, M P Moffat.   

Abstract

1. The effects of the phorbol ester, phorbol myristate acetate (PMA) were examined on function and energy metabolism in the isolated working heart of the rat. 2. At a concentration of 10(-9) M PMA produced a rapid loss in cardiac function in terms of aortic flow rate (AFR) and coronary flow rates (CFR) whereas a similar concentration of 4 alpha-phorbol 12,13-didecanoate was ineffective. At a concentration of 10(-10) M, the PMA-induced depression was more gradual but nevertheless very pronounced with an almost total loss in AFR after 30 min perfusion. The reduction in CFR was more moderate than that observed with respect to AFR. 3. The protein kinase C (PKC) inhibitor (+/-)-1-O-hexadecyl-2-O-acylglycerol significantly attenuated the loss in AFR and CFR following addition of PMA. 4. Two inhibitors of Na+/H+ exchange, amiloride and quinacrine, totally prevented the reduction in AFR. Although the PMA-induced depression in CFR was also attenuated by both amiloride and quinacrine, these effects were not significant, probably reflecting the less pronounced effect of PMA on this parameter. 5. Nifedipine, a dihydropyridine calcium channel blocker reduced PMA toxicity to a similar degree as Na+/N+ exchange inhibition whereas the calcium channel agonist Bay K 8644 was without effect. 6. Tissue content of energy metabolites including high energy phosphates, total adenine nucleotides or lactate were not significantly affected by PMA perfusion. 7. We conclude that PKC activation is necessary for phorbol ester-induced cardiac dysfunction. The consequence of PKC stimulation includes (1) Na+/H+ exchange activation and a subsequent elevation in intracellular calcium [Ca2+]i via Na+/Ca2+ exchange and (2) PKC-dependent phosphorylation of the calcium channel, both of which would produce toxicity by elevation of [Ca21]i. Pharmacological manipulation of any of these steps prevents PMA toxicity by virtue of a reduction in the accumulation of [Ca21]i. PMA effects or their prevention are unrelated to any changes in energy metabolism.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2207502      PMCID: PMC1917591          DOI: 10.1111/j.1476-5381.1990.tb14099.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  21 in total

1.  Techniques for perfusing isolated rat hearts.

Authors:  J R Neely; M J Rovetto
Journal:  Methods Enzymol       Date:  1975       Impact factor: 1.600

2.  Demonstration of a Na+/H+ exchange activity in purified canine cardiac sarcolemmal vesicles.

Authors:  S M Seiler; E J Cragoe; L R Jones
Journal:  J Biol Chem       Date:  1985-04-25       Impact factor: 5.157

Review 3.  The sodium/hydrogen exchange system in cardiac cells: its biochemical and pharmacological properties and its role in regulating internal concentrations of sodium and internal pH.

Authors:  M Lazdunski; C Frelin; P Vigne
Journal:  J Mol Cell Cardiol       Date:  1985-11       Impact factor: 5.000

Review 4.  The role of protein kinase C in cell surface signal transduction and tumour promotion.

Authors:  Y Nishizuka
Journal:  Nature       Date:  1984 Apr 19-25       Impact factor: 49.962

5.  Use of the perfused rat heart to study cardiac metabolism: retrospective and prospective views.

Authors:  J R Williamson; K Kobayashi
Journal:  Basic Res Cardiol       Date:  1984 May-Jun       Impact factor: 17.165

6.  Amiloride inhibits phorbol ester-stimulated Na+/H+ exchange and protein kinase C. An amiloride analog selectively inhibits Na+/H+ exchange.

Authors:  J M Besterman; W S May; H LeVine; E J Cragoe; P Cuatrecasas
Journal:  J Biol Chem       Date:  1985-01-25       Impact factor: 5.157

7.  Na+-H+ exchange in isolated myocytes from adult rat heart.

Authors:  M A Wallert; O Fröhlich
Journal:  Am J Physiol       Date:  1989-08

8.  Mepacrine, a phospholipase inhibitor. A potential tool for modifying myocardial reperfusion injury.

Authors:  H Otani; R M Engelman; R H Breyer; J A Rousou; S Lemeshow; D K Das
Journal:  J Thorac Cardiovasc Surg       Date:  1986-08       Impact factor: 5.209

9.  Effects of amiloride and ouabain on contractile state, Ca and Na fluxes, and Na content in cultured chick heart cells.

Authors:  D Kim; T W Smith
Journal:  Mol Pharmacol       Date:  1986-04       Impact factor: 4.436

10.  Phorbol ester- and diacylglycerol-mediated desensitization of cardiac beta-adrenergic receptors.

Authors:  C J Limas; C Limas
Journal:  Circ Res       Date:  1985-09       Impact factor: 17.367

View more
  7 in total

1.  Protein kinase C phosphorylation of cardiac troponin T decreases Ca(2+)-dependent actomyosin MgATPase activity and troponin T binding to tropomyosin-F-actin complex.

Authors:  T A Noland; J F Kuo
Journal:  Biochem J       Date:  1992-11-15       Impact factor: 3.857

2.  Influence of phorbol esters on contractile force, action potential and calcium current of isolated guinea-pig heart tissues.

Authors:  T Siems; H Brasch
Journal:  Basic Res Cardiol       Date:  1995 Nov-Dec       Impact factor: 17.165

3.  Intramyocardial infusion of tool drugs for the study of molecular mechanisms in ischemic preconditioning.

Authors:  A M Vogt; P Htun; M Arras; T Podzuweit; W Schaper
Journal:  Basic Res Cardiol       Date:  1996 Sep-Oct       Impact factor: 17.165

4.  Contribution of both alpha- and beta-adrenoceptors to the inotropic effects of catecholamines in the rabbit heart.

Authors:  U Jahnel; B Kaufmann; M Rombusch; H Nawrath
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-12       Impact factor: 3.000

5.  Influence of phorbol esters on stimulation-induced noradrenaline release and contractile force of isolated guinea-pig atria.

Authors:  H Brasch
Journal:  Basic Res Cardiol       Date:  1991 May-Jun       Impact factor: 17.165

6.  Mepacrine-induced inhibition of the inward current mediated by 5-HT3 receptors in rat nodose ganglion neurones.

Authors:  P Fan
Journal:  Br J Pharmacol       Date:  1994-07       Impact factor: 8.739

7.  Bryostatin 1, a novel antineoplastic agent and protein kinase C activator, induces human myalgia and muscle metabolic defects: a 31P magnetic resonance spectroscopic study.

Authors:  P F Hickman; G J Kemp; C H Thompson; A J Salisbury; K Wade; A L Harris; G K Radda
Journal:  Br J Cancer       Date:  1995-10       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.